Ic-8 Apthera Iol New Enrollment Post Approval Study
Research payments
$79,200
Through program year 2025, $79,200 in research payments was reported against Ic-8 Apthera Iol New Enrollment Post Approval Study, across 29 payments, paid by Bausch & Lomb Americas Inc..
- Paid by
- Bausch & Lomb Americas Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $47,290 | 13 |
| 2024 | Research | $31,910 | 16 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Vukich Wauwatosa, WI Named on 11 payments
- Cristos Ifantides Denver, CO Named on 7 payments
- Francis Price Indianapolis, IN Named on 3 payments
- Timothy Page Birmingham, MI Named on 2 payments
- Brandon Baartman Omaha, NE Named on 1 payment
- Gregg Feinerman Newport Beach, CA Named on 1 payment
- Charles Crane South Orange, NJ Named on 1 payment
- Navaneet Chailerborisuth Rock Island, IL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.